IGF1R signaling drives antiestrogen resistance through PAK2/PIX activation in luminal breast cancer

被引:33
|
作者
Zhang, Yinghui [1 ]
Wester, Lynn [1 ]
He, Jichao [1 ]
Geiger, Tamar [2 ]
Moerkens, Marja [1 ]
Siddappa, Ram [1 ]
Helmijr, Jean A. [3 ]
Timmermans, Mieke M. [3 ]
Look, Maxime P. [3 ]
van Deurzen, Caroline H. M. [3 ,4 ]
Martens, John W. M. [3 ]
Pont, Chantal [1 ]
de Graauw, Marjo [1 ]
Danen, Erik H. J. [1 ]
Berns, Els M. J. J. [3 ]
Meerman, John H. N. [1 ]
Jansen, Maurice P. H. M. [3 ]
van de Water, Bob [1 ]
机构
[1] Leiden Univ, Leiden Acad Ctr Drug Res, Div Toxicol, Leiden, Netherlands
[2] Tel Aviv Univ, Dept Human Mol Genet & Biochem, Sackler Fac Med, Tel Aviv, Israel
[3] Dept Med Oncol & Canc Genom Netherlands, Rotterdam, Netherlands
[4] Erasmus Univ, Erasmus MC Canc Inst, Dept Pathol, Med Ctr, Rotterdam, Netherlands
关键词
TAMOXIFEN RESISTANCE; P21-ACTIVATED-KINASE-1; PAK1; ENDOCRINE RESISTANCE; CELL-PROLIFERATION; NEURITE OUTGROWTH; GROWTH-FACTORS; BETA-CATENIN; I RECEPTOR; EXPRESSION; PATHWAY;
D O I
10.1038/s41388-017-0027-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Antiestrogen resistance in estrogen receptor positive (ER+) breast cancer is associated with increased expression and activity of insulin-like growth factor 1 receptor (IGF1R). Here, a kinome siRNA screen has identified 10 regulators of IGF1R-mediated antiestrogen with clinical significance. These include the tamoxifen resistance suppressors BMPR1B, CDK10, CDK5, EIF2AK1, and MAP2K5, and the tamoxifen resistance inducers CHEK1, PAK2, RPS6KC1, TTK, and TXK. The p21-activated kinase 2, PAK2, is the strongest resistance inducer. Silencing of the tamoxifen resistance inducing genes, particularly PAK2, attenuates IGF1R-mediated resistance to tamoxifen and fulvestrant. High expression of PAK2 in ER+ metastatic breast cancer patients is correlated with unfavorable outcome after first-line tamoxifen monotherapy. Phospho-proteomics has defined PAK2 and the PAK-interacting exchange factors PIX alpha/beta as downstream targets of IGF1R signaling, which are independent from PI3K/ATK and MAPK/ERK pathways. PAK2 and PIX alpha/beta modulate IGF1R signaling-driven cell scattering. Targeting PIX alpha/beta entirely mimics the effect of PAK2 silencing on antiestrogen re-sensitization. These data indicate PAK2/PIX as an effector pathway in IGF1R-mediated antiestrogen resistance.
引用
下载
收藏
页码:1869 / 1884
页数:16
相关论文
共 50 条
  • [41] Epigenetic silencing of miR-375 induces trastuzumab resistance in HER2-positive breast cancer by targeting IGF1R
    Xing-Ming Ye
    Hua-Yu Zhu
    Wen-Dong Bai
    Ting Wang
    Lei Wang
    Ying Chen
    An-Gang Yang
    Lin-Tao Jia
    BMC Cancer, 14
  • [42] Epigenetic silencing of miR-375 induces trastuzumab resistance in HER2-positive breast cancer by targeting IGF1R
    Ye, Xing-Ming
    Zhu, Hua-Yu
    Bai, Wen-Dong
    Wang, Ting
    Wang, Lei
    Chen, Ying
    Yang, An-Gang
    Jia, Lin-Tao
    BMC CANCER, 2014, 14
  • [43] Downregulation of IGFBP2 is associated with resistance to IGF1R therapy in rhabdomyosarcoma
    Kang, Z.
    Yu, Y.
    Zhu, Y. J.
    Davis, S.
    Walker, R.
    Meltzer, P. S.
    Helman, L. J.
    Cao, L.
    ONCOGENE, 2014, 33 (50) : 5697 - 5705
  • [44] TGF and IGF1R signaling activates protein kinase A through differential regulation of ezrin phosphorylation in colon cancer cells
    Leiphrakpam, Premila D.
    Brattain, Michael G.
    Black, Jennifer D.
    Wang, Jing
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (21) : 8242 - 8254
  • [45] Downregulation of IGFBP2 is associated with resistance to IGF1R therapy in rhabdomyosarcoma
    Z Kang
    Y Yu
    Y J Zhu
    S Davis
    R Walker
    P S Meltzer
    L J Helman
    L Cao
    Oncogene, 2014, 33 : 5697 - 5705
  • [46] 13-elemene induced apoptosis and senescence of triple-negative breast cancer cells through IGF1/IGF1R pathway
    Xie, Lufan
    Zhang, Jianfeng
    Yan, Haibin
    Cai, Yanyang
    Xu, Leilai
    TISSUE & CELL, 2022, 79
  • [47] Igf1r as a therapeutic target in a mouse model of basal-like breast cancer
    Klinakis, Apostolos
    Szabolcs, Matthias
    Chen, Guoying
    Xuan, Shouhong
    Hibshoosh, Hanina
    Efstratiadis, Argiris
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (07) : 2359 - 2364
  • [48] Multiparametric analysis of cell morphology shows that beta-PIX, Cdc42, Rac1, and PAK2 drive YAP activation in breast epithelial cells.
    Sero, J. E.
    Bakal, C.
    MOLECULAR BIOLOGY OF THE CELL, 2016, 27
  • [49] Preclinical evaluation targeting both IGF1R and IR in triple negative breast cancer
    Eustace, A. J.
    Roche, S.
    Mukherjee, N.
    O'Neill, F.
    Conlon, N.
    Meiller, J.
    Collins, D. M.
    Gaule, P.
    Canonici, A.
    Madden, S. F.
    O'Donovan, N.
    Crown, J.
    ANNALS OF ONCOLOGY, 2019, 30
  • [50] Effects of Src and IGF1R inhibition on acquired endocrine therapy resistant breast cancer
    Liu, Shuyling
    Meng, Xiaolong
    Liu, Wenbin
    Miller, Todd
    Lu, Yiling
    Zhang, Fan
    Arteaga, Carlos L.
    Mills, Gordon B.
    Gonzalez-Angulo, Ana M.
    CANCER RESEARCH, 2012, 72